Chemsex and its impact on gay and bisexual men who have sex with men: Findings from an online survey in Belgium.
chemsex
gbMSM
mental health
pharmacosex
sexual consent
sexual health
sexualized drug use
Journal
HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392
Informations de publication
Date de publication:
03 Oct 2024
03 Oct 2024
Historique:
received:
12
06
2024
accepted:
09
09
2024
medline:
4
10
2024
pubmed:
4
10
2024
entrez:
4
10
2024
Statut:
aheadofprint
Résumé
The study aimed to estimate the prevalence of sexualized drug use, or chemsex, in a wide group of gay, bisexual and other men who have sex with men (gbMSM) in Belgium. It examined which drugs gbMSM used before and during sex, the frequency with which they used it, whether they experienced non-consensual sex, and evaluated the impact of chemsex on the health and professional and social lives of respondents. We conducted an online survey among Belgian gbMSM. Five specific questions on chemsex were included in the survey. These questions assessed whether gbMSM engaged in chemsex. If they did, they were asked to provide information on which drugs they had used and how often. We asked whether their and their partners' boundaries had been respected and whether and how engaging in chemsex had affected a range of life domains. Of 836 respondents, 258 (30.9%) self-reported having had sex under the influence of substances ("chemsex") in the previous 6 months. Of these, 227 (88%) were considered chemsex users according to the definition used for the analysis. Poppers (73%), gamma-hydroxybutyrate/gamma-butyrolactone (GHB/GBL; 69%) and cathinones (68%) were the most commonly reported substances. Almost half of respondents (45%) engaging in chemsex were high on drugs during at least half of their sexual encounters. Nearly 1 in 10 (9%) reported that boundaries had not been respected, suggesting non-consensual sexual activities. The 82 respondents experiencing negative impacts from their chemsex use reported that mental health (65%), physical health (40%) and sexual health (38%) were most impacted. Our findings provide a snapshot of the current chemsex situation in Belgium. The frequency of chemsex is concerning because several health, professional and social aspects are impacted. Almost 1 in 10 respondents using chemsex reported that chemsex impacted consent around sex, requiring additional efforts to eradicate these non-consensual sexual experiences. Therefore, larger scale research focusing on respected boundaries and consent during chemsex and the frequency of drug use for sex seems required. Additionally, sensitisation, as well as care and support programmes are critical.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.
Références
World Health Organization. Consolidated Guidelines on HIV, Viral Hepatitis and STI Prevention, Diagnosis, Treatment and Care for Key Populations. World Health Organization; 2022.
Bourne A, Reid D, Hickson F, Torres S, Weatherburn RP. The Chemsex study: drug use in sexual settings among gay and bisexual men in Lambeth, Southwark & Lewisham. Public Health England. 2014; Available from: www.sigmaresearch.org.uk/chemsex
Coronado‐Muñoz M, García‐Cabrera E, Quintero‐Flórez A, Román E, Vilches‐Arenas Á. Sexualized drug use and Chemsex among men who have sex with men in Europe: a systematic review and meta‐analysis. J Clin Med. 2024;13(6):13.
Schmidt A, Weatherburn P. European MSM internet survey [Internet]. AIDS‐Conference; 2018 Available from: www.sigmaresearch.org.uk
Jaspal RC. Identity and sexual health among gay and bisexual men. Int J Environ Res Public Health. 2022;19(19):12124.
Weatherburn P, Hickson F, Reid D, Torres‐Rueda S, Bourne A. Motivations and values associated with combining sex and illicit drugs ('chemsex’) among gay men in South London: findings from a qualitative study. Sex Transm Infect [Internet]. 2017;93(3):203‐206.
Stuart D. Sexualised drug use by MSM: background, current status and response. HIV Nursing. 2013;13:6‐10.
Kirby T, Thornber‐Dunwell M. High‐risk drug practices tighten grip on London gay scene. Lancet. 2013;381(9861):101‐102.
Edmundson C, Heinsbroek E, Glass R, et al. Sexualised drug use in the United Kingdom (UK): a review of the literature. Int J Drug Policy. 2018;55:131‐148.
Macfarlane A. Sex, drugs and self‐control: why chemsex is fast becoming a public health concern. J Fam Plann Reprod Health Care. 2016;42(4):291‐294.
Vanbaelen T, Rotsaert A, De Baetselier I, et al. Doxycycline post‐exposure prophylaxis among men who have sex with men and transgender women in Belgium: awareness, use and antimicrobial resistance concerns in a cross‐sectional online survey. Sex Transm Infect. 2024. doi:10.1136/sextrans‐2024‐056261
Strong C, Huang P, Li CWW, Ku SWWW, Wu HJJ, Bourne A. HIV, chemsex, and the need for harm‐reduction interventions to support gay, bisexual, and other men who have sex with men. Lancet HIV. 2022;9(10):e717‐e725.
European Monitoring Centre for Drugs and Drug Addiction. Wastewater Analysis and Drugs—A European Multi‐City Study. [cited 2024 March 22] https://www.emcdda.europa.eu/publications/html/pods/waste-water-analysis_en.
Field DJ, de Wit J, Davoren MP, O'Reilly EJ, Den Daas C. Chemsex Anxiety and depression among gay, bisexual and other men who have sex with men living with HIV. AIDS Behav. 2023;27(10):3206‐3212.
Platteau T, Herrijgers C, Florence E, et al. Drug behaviors, sexually transmitted infection prevention, and sexual consent during chemsex: insights generated in the Budd app after each chemsex session. Front Public Health. 2023;11:1160087.
Drückler S, Speulman J, Van Rooijen M, De Vries HJC. Sexual consent and chemsex: a quantitative study on sexualised drug use and non‐consensual sex among men who have sex with men in Amsterdam, The Netherlands. Sex Transm Infect. 2021;97(4):268‐275.
Platteau T, Florence E, de Wit JBF. Self‐control as conceptual framework to understand and support people who use drugs during sex. Front Public Health. 2022;10:10.
Whitlock GG, Protopapas K, Bernardino JI, et al. Chems4EU: chemsex use and its impacts across four European countries in HIV‐positive men who have sex with men attending HIV services. HIV Med. 2021;22:944‐957.
Vanbaelen T, Rotsaert A, Van Landeghem E, et al. Do pre‐exposure prophylaxis (PrEP) users engaging in chemsex experience their participation as problematic and how can they best be supported? Findings from an online survey in Belgium. Sex Health. 2023;20(5):424‐430.
Pakianathan M, Whittaker W, Lee M, et al. Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics. HIV Med. 2018;19(7):485‐490.
Herrijgers C, Platteau T, Vandebosch H, Poels K, Florence E. Using intervention mapping to develop an mHealth intervention to support men who have sex with men engaging in Chemsex (Budd): development and usability study. JMIR Res Protoc. 2022;11(12):e39678.